NASDAQ · Biotechnology

Minerva Neurosciences Inc (NERV)

$2.00 -5.66%
36 In band Daily RSI (14) · 19 Nov 2026

Moving averages

SMA 200$4.84-58.68%

Company profile

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of candidate products for the treatment of diseases of the central nervous system. The company is headquartered in Waltham, Massachusetts.

SectorHealthcare
IndustryBiotechnology
Market cap$127.58M
P/E ratioNone
EPS$-33.83
Beta0.014
Dividend yield0.00%
52-week high$8.80
52-week low$1.96

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for NERV

An email when NERV closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 7:30 AM EST